PRISCILLA QUILTER: Open Payments
NPI 1447336839 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,000 in 68 payments from 10 companies in 2025. Trend: 2023 $1,796 · 2024 $1,241 · 2025 $2,000
Food & beverage: $2,000
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 35 | $990 |
| Janssen Biotech, Inc. | 6 | $365 |
| ABBVIE INC. | 15 | $335 |
| Ardelyx, Inc. | 3 | $75 |
| Gilead Sciences, Inc. | 2 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| PFIZER INC. | 2 | $44 |
| Intercept Pharmaceuticals, Inc. | 1 | $30 |
| Amgen Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $15 |
Products named: VOQUEZNA, TREMFYA, RINVOQ, SKYRIZI, IBSRELA, ENTYVIO, Livdelzi, XELJANZ.
Industry payments across CT — which companies pay providers there.
